Drugs for Life: How Pharmaceutical Companies Define Our Health
Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one-fifth of the U.S. gross domestic product by 2020. In Drugs for Life, Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthca...
Saved in:
| Main Author: | |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Durham
Duke University Press
[2012]
|
| Series: | Experimental futures : technological lives, scientific arts, anthropological voices
|
| Subjects: | |
| Online Access: | DE-1043 DE-1046 DE-859 DE-860 DE-473 DE-703 DE-739 DE-858 Volltext |
| Summary: | Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one-fifth of the U.S. gross domestic product by 2020. In Drugs for Life, Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthcare not only came to be, but also came to be taken for granted. For several years, Dumit attended pharmaceutical industry conferences; spoke with marketers, researchers, doctors, and patients; and surveyed the industry's literature regarding strategies to expand markets for prescription drugs. He concluded that underlying the continual growth in medications, disease categories, costs, and insecurity is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. This perception is based on clinical trials that we have largely outsourced to pharmaceutical companies. Those companies in turn see clinical trials as investments and measure the value of those investments by the size of the market and profits that they will create. They only ask questions for which the answer is more medicine. Drugs for Life challenges our understanding of health, risks, facts, and clinical trials, the very concepts used by pharmaceutical companies to grow markets to the point where almost no one can imagine a life without prescription drugs |
| Item Description: | Description based on online resource; title from PDF title page (publisher's Web site, viewed 28. Okt 2020) |
| Physical Description: | 1 online resource (280 pages) 26 photos, 3 tables |
| ISBN: | 9780822393481 |
| DOI: | 10.1515/9780822393481 |
Staff View
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV047049129 | ||
| 003 | DE-604 | ||
| 005 | 20201210 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 201207s2012 xx o||| o|||| 00||| eng d | ||
| 020 | |a 9780822393481 |9 978-0-8223-9348-1 | ||
| 024 | 7 | |a 10.1515/9780822393481 |2 doi | |
| 035 | |a (ZDB-23-DGG)9780822393481 | ||
| 035 | |a (OCoLC)1226703151 | ||
| 035 | |a (DE-599)BVBBV047049129 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-859 |a DE-860 |a DE-473 |a DE-739 |a DE-1043 |a DE-703 |a DE-858 | ||
| 082 | 0 | |a 338.4/761510973 |2 23 | |
| 100 | 1 | |a Dumit, Joseph |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Drugs for Life |b How Pharmaceutical Companies Define Our Health |c Joseph Dumit |
| 264 | 1 | |a Durham |b Duke University Press |c [2012] | |
| 264 | 4 | |c © 2012 | |
| 300 | |a 1 online resource (280 pages) |b 26 photos, 3 tables | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Experimental futures : technological lives, scientific arts, anthropological voices | |
| 500 | |a Description based on online resource; title from PDF title page (publisher's Web site, viewed 28. Okt 2020) | ||
| 520 | |a Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one-fifth of the U.S. gross domestic product by 2020. In Drugs for Life, Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthcare not only came to be, but also came to be taken for granted. For several years, Dumit attended pharmaceutical industry conferences; spoke with marketers, researchers, doctors, and patients; and surveyed the industry's literature regarding strategies to expand markets for prescription drugs. He concluded that underlying the continual growth in medications, disease categories, costs, and insecurity is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. This perception is based on clinical trials that we have largely outsourced to pharmaceutical companies. Those companies in turn see clinical trials as investments and measure the value of those investments by the size of the market and profits that they will create. They only ask questions for which the answer is more medicine. Drugs for Life challenges our understanding of health, risks, facts, and clinical trials, the very concepts used by pharmaceutical companies to grow markets to the point where almost no one can imagine a life without prescription drugs | ||
| 546 | |a In English | ||
| 650 | 7 | |a SOCIAL SCIENCE / Anthropology / Cultural & Social |2 bisacsh | |
| 650 | 4 | |a Drug utilization |x United States |x Electronic books | |
| 650 | 4 | |a Drug utilization |z United States | |
| 650 | 4 | |a Drugs |x Social aspects |x United States | |
| 650 | 4 | |a Drugs |x Social aspects |z United States | |
| 650 | 4 | |a Pharmaceutical industry |x Social aspects |x United States | |
| 650 | 4 | |a Pharmaceutical industry |x Social aspects |z United States | |
| 856 | 4 | 0 | |u https://doi.org/10.1515/9780822393481 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-198-DUA | ||
| 912 | |a ZDB-23-DGG | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-032456525 | |
| 966 | e | |u https://doi.org/10.1515/9780822393481 |l DE-1043 |p ZDB-23-DGG |q FAB_PDA_DGG |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1515/9780822393481 |l DE-1046 |p ZDB-23-DGG |q FAW_PDA_DGG |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1515/9780822393481 |l DE-859 |p ZDB-23-DGG |q FKE_PDA_DGG |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1515/9780822393481 |l DE-860 |p ZDB-23-DGG |q FLA_PDA_DGG |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1515/9780822393481 |l DE-473 |p ZDB-23-DGG |q UBG_PDA_DGG |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1215/9780822393481 |l DE-703 |p ZDB-198-DUA |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1515/9780822393481 |l DE-739 |p ZDB-23-DGG |q UPA_PDA_DGG |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1515/9780822393481 |l DE-858 |p ZDB-23-DGG |q FCO_PDA_DGG |x Verlag |3 Volltext | |
Record in the Search Index
| _version_ | 1824507749933776896 |
|---|---|
| adam_text | |
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Dumit, Joseph |
| author_facet | Dumit, Joseph |
| author_role | aut |
| author_sort | Dumit, Joseph |
| author_variant | j d jd |
| building | Verbundindex |
| bvnumber | BV047049129 |
| collection | ZDB-198-DUA ZDB-23-DGG |
| ctrlnum | (ZDB-23-DGG)9780822393481 (OCoLC)1226703151 (DE-599)BVBBV047049129 |
| dewey-full | 338.4/761510973 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/761510973 |
| dewey-search | 338.4/761510973 |
| dewey-sort | 3338.4 9761510973 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| discipline_str_mv | Wirtschaftswissenschaften |
| doi_str_mv | 10.1515/9780822393481 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000zc 4500</leader><controlfield tag="001">BV047049129</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20201210</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">201207s2012 xx o||| o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780822393481</subfield><subfield code="9">978-0-8223-9348-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1515/9780822393481</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-23-DGG)9780822393481</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1226703151</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047049129</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-859</subfield><subfield code="a">DE-860</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-1043</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-858</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/761510973</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Dumit, Joseph</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drugs for Life</subfield><subfield code="b">How Pharmaceutical Companies Define Our Health</subfield><subfield code="c">Joseph Dumit</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Durham</subfield><subfield code="b">Duke University Press</subfield><subfield code="c">[2012]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (280 pages)</subfield><subfield code="b">26 photos, 3 tables</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Experimental futures : technological lives, scientific arts, anthropological voices</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based on online resource; title from PDF title page (publisher's Web site, viewed 28. Okt 2020)</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one-fifth of the U.S. gross domestic product by 2020. In Drugs for Life, Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthcare not only came to be, but also came to be taken for granted. For several years, Dumit attended pharmaceutical industry conferences; spoke with marketers, researchers, doctors, and patients; and surveyed the industry's literature regarding strategies to expand markets for prescription drugs. He concluded that underlying the continual growth in medications, disease categories, costs, and insecurity is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. This perception is based on clinical trials that we have largely outsourced to pharmaceutical companies. Those companies in turn see clinical trials as investments and measure the value of those investments by the size of the market and profits that they will create. They only ask questions for which the answer is more medicine. Drugs for Life challenges our understanding of health, risks, facts, and clinical trials, the very concepts used by pharmaceutical companies to grow markets to the point where almost no one can imagine a life without prescription drugs</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">In English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SOCIAL SCIENCE / Anthropology / Cultural & Social</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug utilization</subfield><subfield code="x">United States</subfield><subfield code="x">Electronic books</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug utilization</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Social aspects</subfield><subfield code="x">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Social aspects</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Social aspects</subfield><subfield code="x">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Social aspects</subfield><subfield code="z">United States</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1515/9780822393481</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-198-DUA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-23-DGG</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032456525</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1515/9780822393481</subfield><subfield code="l">DE-1043</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">FAB_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1515/9780822393481</subfield><subfield code="l">DE-1046</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">FAW_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1515/9780822393481</subfield><subfield code="l">DE-859</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">FKE_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1515/9780822393481</subfield><subfield code="l">DE-860</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">FLA_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1515/9780822393481</subfield><subfield code="l">DE-473</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">UBG_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1215/9780822393481</subfield><subfield code="l">DE-703</subfield><subfield code="p">ZDB-198-DUA</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1515/9780822393481</subfield><subfield code="l">DE-739</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">UPA_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1515/9780822393481</subfield><subfield code="l">DE-858</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">FCO_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV047049129 |
| illustrated | Illustrated |
| index_date | 2024-07-03T16:07:30Z |
| indexdate | 2025-02-19T17:29:41Z |
| institution | BVB |
| isbn | 9780822393481 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032456525 |
| oclc_num | 1226703151 |
| open_access_boolean | |
| owner | DE-1046 DE-859 DE-860 DE-473 DE-BY-UBG DE-739 DE-1043 DE-703 DE-858 |
| owner_facet | DE-1046 DE-859 DE-860 DE-473 DE-BY-UBG DE-739 DE-1043 DE-703 DE-858 |
| physical | 1 online resource (280 pages) 26 photos, 3 tables |
| psigel | ZDB-198-DUA ZDB-23-DGG ZDB-23-DGG FAB_PDA_DGG ZDB-23-DGG FAW_PDA_DGG ZDB-23-DGG FKE_PDA_DGG ZDB-23-DGG FLA_PDA_DGG ZDB-23-DGG UBG_PDA_DGG ZDB-23-DGG UPA_PDA_DGG ZDB-23-DGG FCO_PDA_DGG |
| publishDate | 2012 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | Duke University Press |
| record_format | marc |
| series2 | Experimental futures : technological lives, scientific arts, anthropological voices |
| spelling | Dumit, Joseph Verfasser aut Drugs for Life How Pharmaceutical Companies Define Our Health Joseph Dumit Durham Duke University Press [2012] © 2012 1 online resource (280 pages) 26 photos, 3 tables txt rdacontent c rdamedia cr rdacarrier Experimental futures : technological lives, scientific arts, anthropological voices Description based on online resource; title from PDF title page (publisher's Web site, viewed 28. Okt 2020) Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one-fifth of the U.S. gross domestic product by 2020. In Drugs for Life, Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthcare not only came to be, but also came to be taken for granted. For several years, Dumit attended pharmaceutical industry conferences; spoke with marketers, researchers, doctors, and patients; and surveyed the industry's literature regarding strategies to expand markets for prescription drugs. He concluded that underlying the continual growth in medications, disease categories, costs, and insecurity is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. This perception is based on clinical trials that we have largely outsourced to pharmaceutical companies. Those companies in turn see clinical trials as investments and measure the value of those investments by the size of the market and profits that they will create. They only ask questions for which the answer is more medicine. Drugs for Life challenges our understanding of health, risks, facts, and clinical trials, the very concepts used by pharmaceutical companies to grow markets to the point where almost no one can imagine a life without prescription drugs In English SOCIAL SCIENCE / Anthropology / Cultural & Social bisacsh Drug utilization United States Electronic books Drug utilization United States Drugs Social aspects United States Pharmaceutical industry Social aspects United States https://doi.org/10.1515/9780822393481 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Dumit, Joseph Drugs for Life How Pharmaceutical Companies Define Our Health SOCIAL SCIENCE / Anthropology / Cultural & Social bisacsh Drug utilization United States Electronic books Drug utilization United States Drugs Social aspects United States Pharmaceutical industry Social aspects United States |
| title | Drugs for Life How Pharmaceutical Companies Define Our Health |
| title_auth | Drugs for Life How Pharmaceutical Companies Define Our Health |
| title_exact_search | Drugs for Life How Pharmaceutical Companies Define Our Health |
| title_exact_search_txtP | Drugs for Life How Pharmaceutical Companies Define Our Health |
| title_full | Drugs for Life How Pharmaceutical Companies Define Our Health Joseph Dumit |
| title_fullStr | Drugs for Life How Pharmaceutical Companies Define Our Health Joseph Dumit |
| title_full_unstemmed | Drugs for Life How Pharmaceutical Companies Define Our Health Joseph Dumit |
| title_short | Drugs for Life |
| title_sort | drugs for life how pharmaceutical companies define our health |
| title_sub | How Pharmaceutical Companies Define Our Health |
| topic | SOCIAL SCIENCE / Anthropology / Cultural & Social bisacsh Drug utilization United States Electronic books Drug utilization United States Drugs Social aspects United States Pharmaceutical industry Social aspects United States |
| topic_facet | SOCIAL SCIENCE / Anthropology / Cultural & Social Drug utilization United States Electronic books Drug utilization United States Drugs Social aspects United States Pharmaceutical industry Social aspects United States |
| url | https://doi.org/10.1515/9780822393481 |
| work_keys_str_mv | AT dumitjoseph drugsforlifehowpharmaceuticalcompaniesdefineourhealth |